Benzinga | Jan 7, 2022 01:01PM EST

Morgan Stanley Downgrades Zimmer Biomet Holdings to Equal-Weight, Lowers Price Target to $145

Morgan Stanley analyst Cecilia Furlong downgrades Zimmer Biomet Holdings (NYSE:ZBH) from Overweight to Equal-Weight and lowers the price target from $165 to $145.